Vyne Therapeutics Inc.NASDAQ: VYNE

Yarrow Bioscience Investor Presentation

· Issued by Vyne Therapeutics Inc.
Presentations

Yarrow Bioscience Investor Presentation
May 21, 2026

Repibresib Phase 2b Vitiligo Topline Results & Additional Analyses
July 30, 2025

VYN202 PsO Phase 1b Data Presentation
July 2, 2025

VYN202 P1a SAD/MAD Data
December 23, 2024

SID 2024: VYNE Posters
May 19, 2024

Upcoming Events
Past Events

VYNE Therapeutics and Yarrow Bioscience Merger Conference Call
December 17, 2025

Piper Sandler 33rd Annual Virtual Healthcare Conference
Listen to Webcast
November 22, 2021 at 10:00 AM EST

Earlier from Vyne Therapeutics

All Vyne Therapeutics news releases